GRL-098-22
GRL-098-22 (Compound 6t) is a potent inhibitor targeting G protein-coupled receptor kinase 5 (GRK5) and GRK6 with IC50 values of 0.6 μM and 0.19 μM, respectively. GRL-098-22 is promising for research of diseases such as heart failure and multiple myeloma[1].
Product Specifications
UNSPSC
12352005
Target
G Protein-coupled Receptor Kinase (GRK)
Related Pathways
GPCR/G Protein
Field of Research
Cancer; Cardiovascular Disease
Smiles
O=C(N1C[C@@H](C(NC2=C(C)NC(/C=C3C(NC4=C\3C=C(C(N[C@@H](C5=CC=C(F)C=C5)C)=O)C=C4)=O)=C2C)=O)NCC1)OC(C)(C)C
Molecular Formula
C34H39FN6O5
Molecular Weight
630.71
Shipping Conditions
Room temperature
Scientific Category
Reference compound1
Clinical Information
No Development Reported
Frequently Asked Questions
More Discoveries
Explore Other Products
Browse additional items from our catalog
BNC680226-100 1x 100 µL
Pmel17 / gp100 / SILV (NKI-beteb), CF568 conjugate, 0.1mg/mL
Sign In for Pricing
View Details 
BNC140017-100 1x 100 µL
Ep-CAM / CD326 (VU-1D9), CF514 conjugate, 0.1mg/mL
Sign In for Pricing
View Details 
BNC680855-500 1x 500 µL
Retinol Binding Protein-1 (G4E4), CF568 conjugate, 0.1mg/mL
Sign In for Pricing
View Details 
BNC942556-500 1x 500 µL
Spectrin Alpha 1 (Erythrocyte Marker) (rSPTA1/1833), CF594 conjugate, 0.1mg/mL
Sign In for Pricing
View Details